Maximizing Operational Productivity through Ultra-Fast Analysis with Nexera X4

Significance of the topic

High-throughput chromatographic analysis is essential in pharmaceutical development and routine quality control because faster cycle times increase sample throughput, accelerate decision-making, and reduce operational costs per analysis. Improvements in solvent delivery responsiveness, low internal volume flow paths and reduced dead volume directly affect the ability to run reliable ultra-fast gradient methods while maintaining chromatographic fidelity and quantitative reproducibility.

Objectives and overview of the study

The study demonstrates the performance of the Nexera X4 ultra-high-performance liquid chromatograph (UHPLC) for ultra-fast gradient analysis of a mixed standard of nine small-molecule pharmaceuticals. The primary objectives were to show that a low internal volume design together with advanced pump technology reduces cycle time (to a 3-minute gradient cycle) without compromising retention time stability or peak-area reproducibility, thereby enabling higher laboratory productivity.

Methodology and experimental approach

The work used a model mixed standard of low-molecular-weight pharmaceutical compounds analyzed in a 3-minute gradient method. Key experimental parameters included: a binary mobile phase (0.1% formic acid in water and acetonitrile) with a steep gradient from 5% to 95% organic between 0 and ~1.4–1.8 min and re-equilibration to 5% by 3 min; a short, sub-50 mm C18 column packed with 1.9 μm particles; a high flow rate of 1.2 mL/min; and small injection volumes (1 μL) with a 15 μL sample loop. Detection was performed by UV at 254 nm. Performance was assessed by overlaying chromatograms from six replicate injections and by calculating %RSD for retention times and peak areas.

Used instrumentation

• Chromatograph: Shimadzu Nexera X4 UHPLC system
• Pump features: independently actuated plungers and pressure feedback mechanism to reduce pulsation and stabilize flow under ultra-high-pressure conditions
• Column: Shim-pack Scepter C18-120, 50 mm × 2.1 mm I.D., 1.9 μm
• Mixer: micro mixer
• Detector: SPD-M40 X4 UV detector, STD cell, monitoring at 254 nm
• Fittings: end-surface-sealed high-pressure connections and tool-free fittings throughout high-pressure flow paths to minimize dead volume and carryover

Main results and discussion

The Nexera X4 achieved reproducible separation and quantitation in a 3-minute cycle for a mixture of nine small-molecule drugs. Key findings include:

• Excellent overlay of six replicate chromatograms, indicating stable chromatographic profiles across runs.
• Very low %RSD values for retention times (range approximately 0.01–0.07%) and peak areas (approximately 0.30–0.40%) across six injections, demonstrating both retention and quantitative reproducibility suitable for routine high-throughput work.
• The low internal volume architecture and rapid solvent delivery response shortened gradient re-equilibration and contributed to reduced cycle times without observable loss of chromatographic quality.
• End-surface-sealed connections and tool-free fittings helped minimize dead volume-related peak broadening and reduced carryover risk, improving robustness in high-throughput sequences.

These results indicate that hardware innovations in solvent delivery and flow-path design can support ultra-fast UHPLC gradients while preserving the precision required for pharmaceutical analyses.

Benefits and practical applications

The demonstrated performance offers several practical advantages:

• Increased sample throughput for multi-sample pharmaceutical workflows such as stability testing, batch release, impurity profiling and method screening.
• Reduced per-sample time and solvent consumption per sample due to shorter cycle times and efficient re-equilibration.
• Improved chromatographic reproducibility and robustness in demanding high-pressure, fast-gradient applications, which simplifies method transfer and routine QC implementation.
• Enhanced usability through tool-free fittings that speed maintenance and reduce downtime.

Future trends and potential applications

Advances illustrated by Nexera X4 align with broader trends in LC: higher-pressure-capable systems coupled with sub-2 μm or core-shell stationary phases will enable even faster separations; tighter integration with high-resolution mass spectrometry will expand targeted and untargeted screening in high-throughput formats; automated method scouting and AI-driven optimization will shorten method development cycles; and multiplexed or parallel LC configurations may further increase lab throughput. Additionally, continued focus on minimizing solvent use and integrating greener mobile-phase strategies will be important for sustainable high-throughput workflows. It is important to balance ultra-fast methods with validation requirements and column lifetime considerations in routine use.

Conclusion

The Nexera X4 demonstrates that combining a low internal volume flow path, advanced pump design (independently actuated plungers with pressure feedback), and careful high-pressure fittings enables reproducible ultra-fast gradient UHPLC analyses. The system achieved a reliable 3-minute cycle for a multi-component pharmaceutical standard with excellent retention time and peak-area reproducibility, indicating clear potential to maximize productivity in pharmaceutical and analytical laboratories while maintaining data quality.

References

• Shimadzu Corporation. Nexera X4 Ultra High-Performance Liquid Chromatograph — Application Note (First Edition, Feb. 2026).